Syneos Health, Inc. (SYNH) Tops Q3 EPS by 14c, Offers FY20 and FY21 Guidance

Syneos Health, Inc. (NASDAQ: SYNH) reported Q3 EPS of $1.04, $0.14 better than the analyst estimate of $0.90. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.12 billion.

GUIDANCE:

Syneos Health, Inc. sees FY2020 EPS of $3.33-$3.46, versus the consensus of $3.24. Syneos Health, Inc. sees FY2020 revenue of $4.37-4.44 billion, versus the consensus of $4.52 billion.

Syneos Health, Inc. sees FY2021 revenue of $4.9-5.1 billion, versus the consensus of $5.03 billion.

For earnings history and earnings-related data on Syneos Health, Inc. (SYNH) click here.

You May Also Be Interested In

• Schlumberger (SLB) earnings in-line, revenue beats expectations
• Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance
• Fifth Third Bancorp (FITB) Tops Q1 EPS by 2c